These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 2215761)
21. [Greater control over drugs in the EEC]. Sygeplejersken; 1994 Jan; 94(4):34. PubMed ID: 7940299 [No Abstract] [Full Text] [Related]
22. Secrecy and transparency of medicines licensing in the EU. Abraham J; Lewis G Lancet; 1998 Aug; 352(9126):480-2. PubMed ID: 9708771 [No Abstract] [Full Text] [Related]
23. [European registration of medicines: pros and cons for prescriber and patient]. Offerhaus L Ned Tijdschr Geneeskd; 1997 May; 141(21):1028-33. PubMed ID: 9340558 [TBL] [Abstract][Full Text] [Related]
24. [Two years with EMEA: towards a unified drug registration within the EEC]. Lennholm B Lakartidningen; 1997 Jan; 94(1-2):8-12. PubMed ID: 9053613 [No Abstract] [Full Text] [Related]
25. Regulatory approaches to new psychoactive substances (NPS) in the European Union. Hughes B; Griffiths P Addiction; 2014 Oct; 109(10):1591-3. PubMed ID: 25163707 [No Abstract] [Full Text] [Related]
27. What action for rational drug use? Khan I World Health Forum; 1997; 18(1):83-6. PubMed ID: 9233081 [TBL] [Abstract][Full Text] [Related]
28. [Drug control within the EEC II: good possibilities for Sweden]. Strandberg K Lakartidningen; 1992 Jan; 89(4):178-9. PubMed ID: 1734147 [No Abstract] [Full Text] [Related]
29. Drug and alcohol policy at the global level. Anderson P Drug Alcohol Rev; 2006 Nov; 25(6):485-7. PubMed ID: 17132568 [No Abstract] [Full Text] [Related]
30. The consequences of parallel importing. Morrison CL; Kirk JM Br J Gen Pract; 2003 Jul; 53(492):564. PubMed ID: 14694674 [No Abstract] [Full Text] [Related]
31. Drugs in 2001: a number of ruses unveiled. Prescrire Int; 2002 Apr; 11(58):58-60. PubMed ID: 11987319 [No Abstract] [Full Text] [Related]
32. EU consensus lacking on needle exchange. Alcorn K J Int Assoc Physicians AIDS Care; 1998 Jun; 4(6):37. PubMed ID: 11365534 [TBL] [Abstract][Full Text] [Related]
34. Future European health care: cost containment, health care reform and scientific progress in drug research. Emilien G Int J Health Plann Manage; 1997; 12(2):81-101. PubMed ID: 10173136 [TBL] [Abstract][Full Text] [Related]
35. European regulatory authorities and pediatric labeling. Autret E Pediatrics; 1999 Sep; 104(3 Pt 2):614-8. PubMed ID: 10469802 [No Abstract] [Full Text] [Related]
36. [Eurothemes. Payment according to labor: incentives and stimulating development]. Spanjer JM Ned Tijdschr Geneeskd; 1989 Nov; 133(44):2190-2. PubMed ID: 2812115 [No Abstract] [Full Text] [Related]
37. [Quality control in the pharmaceutical industry]. Sloot HA Pharm Weekbl; 1968 Apr; 103(17):506-16. PubMed ID: 5665061 [No Abstract] [Full Text] [Related]
38. Rationale drug therapy: reasons for failure and suggestions for its implementation. Mathur GP; Kushwaha KP; Mathur S Indian Pediatr; 1993 Jun; 30(6):815-8. PubMed ID: 7726879 [No Abstract] [Full Text] [Related]
39. Pharmaceutical product integrity: can the FDA assure quality? Bernstein I Manag Care; 2004 Mar; 13(3 Suppl):30-3. PubMed ID: 15074168 [No Abstract] [Full Text] [Related]
40. International models. Home care in Europe and The Netherlands. Tjassing HJ Caring; 1995 Jan; 14(1):20-4. PubMed ID: 10172211 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]